A B S T R AC T
Background. It is unknown whether the selection of healthier patients for ateriovenous fistula (AVF) placement explains higher observed catheter-associated mortality among elderly hemodialysis patients. Methods. From the United States Renal Data System 2005-2007, we used proportional hazard models to examine 117 277 incident hemodialysis patients aged 67-90 years for the association of initial vascular access type and 5-year mortality after accounting for health status. Health status was defined as functional status at dialysis initiation and number of hospital days within 2 years prior to dialysis initiation. Results. Patients with catheter alone had more limited functional status (25.5 versus 10.8% of those with AVF) and 3-fold more prior hospital days than those with AVF (mean 18.0 versus 5.4). In the unadjusted model, the likelihood of death was higher for arteriovenous grafts (AVG) {Hazard ratio (HR) Conclusions. The observed attenuation in mortality differences previously attributed to access type alone suggests the existence of selection bias. Nevertheless, the persistence of an apparent survival advantage after adjustment for health status suggests that AVF should still be the access of choice for elderly individuals beginning hemodialysis until more definitive data eliminating selection bias become available.
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I N T RO D U C T I O N
Given the lower rates of morbidity and mortality associated with use of arteriovenous fistula (AVF) as compared with arteriovenous grafts (AVG) and central venous catheters, AVF are the recommended type of vascular access for hemodialysis across all patient populations [1] Although elderly dialysis patients have limited life expectancy and more comorbid conditions compared with their younger counterparts [2, 3] , prior observational studies have shown that AVF use remains associated with greater survival even among the elderly [4, 5] .
However, a recent large systematic review of published vascular access-associated outcomes acknowledges a high risk of selection bias [6] . Nephrologists may be less likely to refer patients for AVF placement if they are not expected to survive to dialysis or if they are expected to have limited survival once dialysis is started. In other words, providers may be selecting healthier patients for AVF placement, which in turn may partially explain the observed survival benefit attributed to AVF when compared with AVG or catheter. We hypothesized that health status, which we defined as functional status at dialysis initiation and number of hospital days in the 2 years prior to dialysis initiation, would attenuate the mortality risk associated with catheter use among elderly patients initiating dialysis.
M AT E R I A L S A N D M E T H O D S

Study sample
Using data obtained from the United States Renal Data System (USRDS), we assembled a cohort of 118 968 incident hemodialysis patients aged 67-90 years who initiated maintenance hemodialysis between 1 January 2005 and 31 December 2007. While an analysis of the elderly would usually start at the age of 65 years, we restricted our analysis to those aged >67 in order to include Medicare claims data for 2 years before the initiation of dialysis at which time all patients would have been potentially eligible for Medicare based on age. We excluded 1691 patients without vascular access data for a final cohort of 117 277 patients.
Data source
The USRDS collects, analyzes and distributes information on all treated end-stage renal disease patients in the United States. Data from the patients' file, the Medical Evidence file and Hospital files were merged to create the final dataset.
Primary outcome
Our primary outcome was time to death, censoring at 5 years after initiating maintenance hemodialysis. As the data source does not include information about changes in vascular access type after dialysis initiation, we examined the 5-year endpoint as an intention-to-treat analysis.
Primary predictor
The primary predictor was vascular access type. We defined vascular access type as a five-level categorical variable (AVF, reference), AVG, catheter with maturing AVF (catheter plus AVF), catheter with maturing AVG (catheter plus AVG), or catheter only using data from the Medical Evidence Form 2728, which asks: 'What access was used on first outpatient dialysis?' and 'If not AVF, then: Is maturing AVF present? Is maturing graft present?' Covariates Our primary covariate was health status. There is no single standard health status measure for individuals or population groups. While health status has been measured using individual subjective perception of health and objective observer ratings, neither method is currently available in the USRDS administrative dataset. Therefore, we defined health status using two separate available variables: functional status and number of hospital days in the 2 years prior to initiating maintenance hemodialysis. Functional status was defined as normal (reference) or limited. Functional status was considered limited if comorbid conditions on the Medical Evidence Form 2728 included inability to ambulate, inability to transfer, needs assistance with activities of daily living, or institutionalized. Number of hospital days in the 2 years prior to initiating dialysis were categorized as 0-7 days (reference), 8-30, 31-60 or >60. The choice to consider hospitalization in the 2 years prior to initiation of dialysis was somewhat arbitrary but was based on the assumption that decisions about the type of vascular access would likely be made in the year before dialysis and might be influenced by prior hospitalizations. In a sensitivity analysis, we considered only hospitalizations within 1 year of dialysis initiation.
Covariates included demographics (age, gender and race), body mass index and albumin (as indicators of nutritional status), hemoglobin, comorbid conditions, Medicaid insurance (as an indicator of socioeconomic status) and nephrology care prior to dialysis initiation (as a marker for emergent placement for vascular access). We considered age as a continuous variable in the primary analysis. Race was defined as White (reference), Black, Asian or other. Body mass index was defined as a three-level variable [18.5-24.9 (reference), ≥25.0 or <18.5]. Albumin and hemoglobin were considered as continuous variables. Individuals were categorized as having Medicaid insurance (no Medicaid insurance reference) if Medicaid was noted as the medical coverage at the time of dialysis initiation. Nephrology care prior to dialysis was defined as a four-level variable (none, <6 months, >6 months and unknown). Comorbid conditions (current or within prior 10 years) were ascertained by checkbox on the Form 2728 at dialysis initiation and were therefore defined as binary indicators [no (reference)/yes]. We included diabetes, diabetes with retinopathy, atherosclerotic heart disease, malignant neoplasm, congestive heart failure, chronic obstructive pulmonary disease, cerebrovascular disease, hypertension, other cardiac disease and peripheral vascular disease.
Statistical analyses
Patient characteristics were examined by vascular access type using χ 2 test for non-continuous variables and ANOVA for continuous variables. No covariates were significantly collinear (r < 0.02). We fit Cox proportional hazards models to examine mortality rates within 6 months of initiating hemodialysis by vascular access type. We first estimated the unadjusted hazard ratios (HRs), then adjusted for 'usual' covariates including age, gender, race, body mass index, comorbid conditions, Medicaid insurance and nephrology care prior to dialysis initiation and finally added our health status variables (hospital days in the previous 2 years and functional status) and calculated the percent changes in the log HRs for each access level across models. Because albumin was missing among 22.8% and hemoglobin among 8.5%, they were not included in the primary analysis. We performed a sensitivity
O R I G I N A L A R T I C L E
A c c e s s -a s s o c i a t e d m o r t a l i t y analysis examining only records with available albumin and hemoglobin data.
We tested for interaction between age category and access type in the final model and stratified by age category to determine whether the association of access type with mortality varied by age categories (67-70, >70-80 and >80-90). Finally, because the proportional hazards assumption was violated (P < 0.001), we compared relative hazards for access type association with 6-month, 1-year and 5-year mortality. All analyses were performed with Stata v. 12.0 (StataCorp, College Station, TX, USA).
R E S U LT S
Of the 117 277 incident hemodialysis patients who met our study criteria, 79.1% (n = 96 169) initiated hemodialysis with a catheter. Among those initiating hemodialysis with a catheter, only 18.2% (n = 17 556) and 4.2% (n = 4073) also had a maturing AVF or AVG, respectively. Patient characteristics by vascular access type are shown in Table 1 . Patients with a catheter alone had poorer health status (limited functional status and more than seven hospital days in the 2 years prior to dialysis initiation), worse indicators of nutritional status (very low body mass index and lower albumin) and were more likely to lack nephrology care prior to dialysis initiation than all other access types (P < 0.001). Those with AVF were less likely to have these indicators, and the proportion of patients with these indicators increased in a stepwise fashion between AVF and catheter values among those with AVG, catheter plus AVF and catheter plus AVG.
Overall, 68.0% (n = 79 816) of patients died within 5 years of initiating dialysis. The estimated annual death rates among those initiating dialysis with an AVF, AVG, catheter plus AVF, catheter plus AVG and catheter only were 20.4, 24.7, 27.9, 30.5 and 42.1%, respectively. In the unadjusted Cox proportional hazards model, mortality rates in the first 5 years after initiating dialysis were higher for all forms of access when compared with AVF (Table 2 ). This association was attenuated −23.7% (95% CI −22.0, −25.5) overall (AVF versus all other access types) after adjusting for demographics, comorbid conditions, Medicaid insurance and the presence of nephrology care prior to dialysis initiation ( Table 2 ). The association attenuated an additional −19.7% (95% CI −18.2, −21.3) overall (AVF versus all other access types) after adjustment for health status but remained statistically significant. These results are depicted graphically in Figure 1 . Results were essentially unchanged in a sensitivity analysis where hospitalization only over the prior year was considered. Similarly, a sensitivity analysis examining only records with available albumin and hemoglobin data had minimal effects on estimates of mortality risk by access type.
Limited functional status and more hospital days in the 2 years preceding dialysis were associated with higher mortality (HRs, 95% CIs, respectively; Table 3 ). HRs for all other covariates included in this fully adjusted model are shown in Table 3 . There was no evidence that the association between access type and mortality varied by age category (P-interaction = 0.1).
We found statistically significant violations of the proportional hazards assumption (P < 0.001), reflecting attenuation of the HRs for access type with longer follow-up. The patterns were qualitatively similar when we compare the HRs for access type association with 6-month, 1-year and 5-year mortality (Supplementary Table S1 ).
D I S C U S S I O N
While a recent large meta-analysis [6] found catheters to be associated with higher mortality when compared with AVG and AVF among the general hemodialysis population, factors unique to the elderly such as limited life expectancy and high primary failure rate [7, 8] 
However, neither study accounted for patient health status, which may serve as an important proxy for selection bias and, therefore, an important factor in vascular access outcomes [9] . As expected, we found that worse health status was associated both with higher likelihood of starting dialysis with a catheter only and with higher hazard of mortality. Accounting for health status partially attenuated the increased mortality attributed to catheter use at dialysis initiation when compared with AVG or AVF. However, even after adjusting for prior hospitalization and functional status, catheter only use remained associated with a 1.5-fold higher risk of death during the first 5 years of hemodialysis.
Our approach of defining vascular access as a five-level predictor also revealed stepwise increases in mortality risk not apparent in prior studies owing to defining those with catheter and maturing AVF or AVG into the catheter only group. Our finding of differences in mortality risk with our five-level access definition may be due to changing vascular access. We found that catheter plus AVG use was associated with a higher mortality than that found with catheter plus AVF. Although AVG use is associated with higher mortality than AVF, because AVGs are usually ready to use within 2 weeks (thus limiting exposure to catheter-related risk) while AVF maturation is often prolonged particularly among the elderly, one might expect that catheter plus AVG would be associated with lower mortality than catheter plus fistula if observed mortality is attributable primarily to vascular access type. Alternatively, this finding may be due to additive risk of infection of having both AVG and catheter or, in support of our hypothesis, may be because different (i.e. healthier) patients are selected for AVF than AVG. Our findings suggest that factors determining what type of access is placed, rather than just the access itself, may be explanatory.
Our adjustment for health status partially attenuated the risk of mortality associated with catheter use. Further, our health status measures were independent predictors of 
O R I G I N A L A R T I C L E
A c c e s s -a s s o c i a t e d m o r t a l i t y mortality, suggesting that patient-level factors like functional status and hospital days prior to starting dialysis do explain an important portion of the excess risk often attributed to catheter use. This assertion is supported by a recent study [10] , which examined first access placed rather than first access used at dialysis initiation and found that AVG was not associated with increased mortality in octogenarian and nonagenarians, suggesting that patient factors rather than access type alone may explain increased risk. Our study is not without limitations. We did not examine vascular access attempts prior to dialysis, which could introduce selection bias based on achieved vascular access. We also lacked information about vascular access changes after dialysis initiation. In a study of >25 000 US adult incident hemodialysis patients [11] , among those initiating dialysis with a catheter alone, fewer than half were still using a catheter alone at 1 year. Changes in vascular access may attenuate mortality risk over time. Alternatively, attenuation in mortality risk over time may be due to a threshold effect in which increased mortality risk levels off at a certain period of survival. The Medical Evidence Form 2728 does not include markers of dialysis adequacy and ascertains comorbidities in a simple 'no/yes' fashion, so differences in dialysis adequacy and disease severity that may affect mortality as well as vascular access choices for individual patients are not captured. Our measure of health status may have partially compensated for this limitation. However, that our adjustment for health status did not fully attenuate the association may be a limitation of our ability to accurately assess health status in an administrative dataset. For example, self-rated health and the 'surprise' question ('Would I be surprised if this patient died in the next 12 months?') have been each shown to have greater than 3-fold association with mortality among dialysis patients [12, 13] but are not currently captured in our dataset. Consideration should be given to adding these predictors to the Medical Evidence Form 2728 completed for every dialysis patient. On the other hand, the lack of full attenuation may be attributable to true vascular access-mediated mortality. That catheter use might confer higher mortality than other forms of vascular access types is understandable, given that permanent access (AVF or AVG) provides several advantages over catheters, including lower rates of infection [14, 15] , septicemia [16] , thrombosis and central venous stenosis [11, 17] . However, in light of the uncertainty around life expectancy and poorer AVF maturation among the elderly [2, 3] , it is plausible that the observed associations between access type and mortality would not hold in this population.
Factors other than health status may also contribute to selection bias. For example, the large observed differences between US versus European catheter use [18] suggest factors such as physician practice patterns [19] , regional variation [20] and patient preferences and goals [2, 3, 21, 22] are also important. A randomized controlled trial would be needed to eliminate selection bias, but such a trial may be considered unethical by many clinicians. A large-scale longitudinal observational cohort study that includes changes in vascular access would help determine whether attenuation in risk over time is attributable to achieving 'safer' access, catheters appearing safer over time, or a survivorship bias. Further studies with additional measures of health status and other factors contributing to selection bias are also needed to fully assess vascular access-associated mortality in the elderly. Similar studies in countries with a lower prevalence of catheter use could also be illuminating.
In conclusion, the observed attenuation in mortality differences previously attributed to access type alone suggests the existence of selection bias. Nevertheless, the persistence of an apparent survival advantage after adjustment for health status suggests that AVF should still be the access of choice for elderly individuals beginning hemodialysis until more definitive data eliminating selection bias become available.
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